Related Experiment Video
Updated: Nov 29, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Prevalence of dyslipidemia in children from 2 to 9 years old
Josianne Alves de Freitas Maia1, Francisco José Maia Pinto2, Francisco Regis da Silva2
1Sociedade Beneficente São Camilo, Hospital São Raimundo. Limoeiro do Norte, Ceará, Brazil.
Objective:
Analyze the occurrence of dyslipidaemia and associated factors in children aged 2 to 9 years.
Method:
Cross-sectional study, carried out with 700 children, in a region of Northeast Brazil. For comparison of means, Student's t test was used; and, for the comparison of medians, the Mann-Whitney test.
Results:
A prevalence of dyslipidaemia of 68.4% was found. In isolation, the majority had a level of: total desirable cholesterol (386; 55.1%), undesirable lipoprotein cholesterol (376; 53.7%), low density lipoproteins - desirable cholesterol (514; 73.4%) and desirable triglyceride (509; 72.7%). In the final multivariate model, only the variable "preschool age" was significant (prevalence ratio = 1.14), indicating that these children are more likely to have dyslipidaemia than those of school age.
Conclusion:
An association was found between dyslipidaemia and preschool age. The need for programs and strategies to better understand this problem is indicated, in addition to preventing early coronary diseases.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

